Overview

Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy and safety of matrifen in patients with severe and chronic pain who can only be sufficiently treated with opioid analgesics (WHO class 3).
Details
Lead Sponsor:
Nycomed
Treatments:
Fentanyl